Yahoo! Finance: VVUS NewsLatest Financial News for VIVUS INCVIVUS to Present at the BioCentury NewsMakers Conference (Business Wire)- August 28, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080828/200808280055... Coverage initiated on Vivus by Leerink Swann (Briefing.com)- August 25, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=VVUS VIVUS INC Financials (EDGAR Online Financials)- August 15, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=vvus VIVUS to Present at the Noble Financial Equity Conference (Business Wire)- August 13, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080813/200808130058... KV Pharma expands license spray-on drug agreement (AP)- August 12, 2008 KV Pharmaceutical Co. on Tuesday said it expanded a partnership with an Australian drug maker, licensing as many as six new drug candidates for development and allowing a broader launch of the hot flash drug Evamist.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080812/kv_pharma.ht... KV 2009 outlook in range of Wall St. estimates (AP)- August 12, 2008 Generic drug maker KV Pharmaceutical Co. forecast fiscal 2009 earnings within range of analysts' expectations. Late Monday, the company said it expects profit of $1.65 to $1.75 per share for the year ending March 31, 2009, with sales of $650 million to $675 million.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080812/kv_pharma_ou... KV Pharma 1Q profit doubles, but sales disappoint (AP)- August 12, 2008 KV Pharmaceutical Co. said its fiscal first-quarter profit more than doubled, but the generic drug maker's revenue fell short of Wall Street expectations.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080812/earns_kv_pha... VIVUS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)- August 8, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/080808/vvus10-q.html VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)- August 6, 2008http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/080806/vvus8-k.html Pharmaceutical company Vivus raises $63.4 million (AP)- August 6, 2008 - Pharmaceutical company Vivus Inc. said Wednesday it raised $63.4 million by selling nearly 8.4 million shares of common stock to institutional investors at $7.77 per share.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080806/vivus_financ... |